Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for MIST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 124.50M
March 31, 2026 117.79M
December 31, 2025 106.24M
September 30, 2025 85.17M
June 30, 2025 53.49M
March 31, 2025 53.46M
December 31, 2024 53.35M
September 30, 2024 53.33M
June 30, 2024 53.27M
March 31, 2024 53.25M
December 31, 2023 33.48M
September 30, 2023 33.48M
June 30, 2023 33.36M
March 31, 2023 33.34M
December 31, 2022 34.29M
Date Value
September 30, 2022 30.39M
June 30, 2022 30.01M
March 31, 2022 29.92M
December 31, 2021 29.90M
September 30, 2021 29.87M
June 30, 2021 29.85M
March 31, 2021 29.85M
December 31, 2020 29.83M
September 30, 2020 24.73M
June 30, 2020 24.69M
March 31, 2020 24.56M
December 31, 2019 24.51M
September 30, 2019 24.49M
June 30, 2019 24.49M
March 31, 2019 23.65M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
InMed Pharmaceuticals, Inc. 5.339M
NervGen Pharma Corp. 106.41M
Clearmind Medicine, Inc. 2.145M
Lexaria Bioscience Corp. 1.652M
Target Group, Inc. (Canada) 617.03M